| Literature DB >> 35573863 |
Linyan Huang1, Li Zhang1,2, Shuiping Jiang1, Baozhu Liang1, Ningning Xu1, Jingxin Li1, Xiaoyan Zhang1,3, Zhen Zhang1.
Abstract
Background: The coronavirus disease 2019 (COVID-19) outbreak has seriously affected people's lives, especially those with chronic diseases. Diabetes self-management, which plays an important role in glycaemic control and reducing the risk of acute and long-term complications, may be discouraged by social distancing. Purpose: To evaluate the level of self-management activities in Chinese patients with type 2 diabetes mellitus (T2DM) during the COVID-19 pandemic. Patients andEntities:
Keywords: coronavirus disease 2019; diabetes self-management; online consultation; type 2 diabetes mellitus
Year: 2022 PMID: 35573863 PMCID: PMC9094639 DOI: 10.2147/DMSO.S351823
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.249
The Demographic Information of the Study Patients
| Variable | All Patients (n=872) | Self-Management Compliance | |||
|---|---|---|---|---|---|
| Good (n=606) | Poor (n=266) | ||||
| Age, Median (IQR) | 58.0(50.0–67.0) | 59.0 (50.0–67.0) | 59.0(52.0–67.0) | 0.118 | |
| Female, n (%) | 383(43.9%) | 272 (44.9%) | 111(41.7%) | 0.747 | 0.387 |
| BMI, kg/m2, n (%) | 18.008 | <0.001 | |||
| Underweight (≤18.4) | 36(4.1%) | 24(4.0%) | 12(4.5%) | ||
| Normal BMI (18.5–23.9) | 416(47.7%) | 317(52.3%) | 99(37.2%) | ||
| Overweight (24.0–27.9) | 293(33.6%) | 189(31.2%) | 104(39.1% | ||
| Obese (≥28) | 99(11.4%) | 58(9.6%) | 41(15.4%) | ||
| Education, n (%) | 6.069 | 0.108 | |||
| Primary school and below | 228(26.1%) | 149(24.6%) | 79(29.7%) | ||
| Junior high | 278(31.9%) | 191(31.5%) | 87(32.7%) | ||
| Senior high | 236(27.1%) | 165(27.2%) | 71(26.7%) | ||
| Bachelor and above | 130(14.9%) | 101(16.7%) | 29(10.9%) | ||
| Living status, n (%) | 5.038 | 0.81 | |||
| Live with family | 808(92.7%) | 568(93.7%) | 240(90.2%) | ||
| Live lonely | 52(6.0%) | 29 (4.8%) | 23(8.6%) | ||
| Other (nursing home, etc.) | 12(1.4%) | 9(1.0%) | 3(0.3%) | ||
| Smoking, n (%) | 195(22.4%) | 124(20.5%) | 71(26.7%) | 4.132 | 0.042 |
| Drinking, n (%) | 115(13.2%) | 72(11.9%) | 43(16.2%) | 2.964 | 0.085 |
Note: We divided patients into two groups based on their self-assessment of diabetes self-management. Chi-square test and Independent-Sample t–Test were used to test for significance.
Abbreviation: BMI, body mass index.
Health and Diabetes-Related Variables of Participants (n = 872)
| Variable | All Patients (n= 872) | Self-Management Compliance | |||
|---|---|---|---|---|---|
| Good (n=606) | Poor (n=266) | ||||
| Diabetes duration, year, median (IQR) | 7.0(3.0–12.0) | 7.0(3.0–12.0) | 10.0(4.0–11.0) | 0.94 | |
| Received diabetes education, n (%) | 643(73.7%) | 522(86.1%) | 121(45.5%) | 157.740 | <0.001 |
| Sources of Diabetes Education, n (%) | 12.868 | 0.045 | |||
| Health professionals | 485(37.8%) | 390(36.6%) | 95(43.8%) | ||
| Community health counseling spot | 283(22.1%) | 243(22.8%) | 40(18.4%) | ||
| Journals/books | 146(11.4%) | 122(11.5%) | 24(11.1%) | ||
| TV/radio | 200(15.6%) | 169(15.9%) | 31(14.3%) | ||
| Internet/APPs | 144(11.2%) | 119(11.2%) | 25(11.5%) | ||
| Others | 24(1.9%) | 22(2.1%) | 2(0.9%) | ||
| Medical history, n (%) | 17.885 | 0.007 | |||
| None | 343(26.5%) | 254(28.9%) | 89(21.5%) | ||
| Hypertension | 409(31.7%) | 275(31.3%) | 134(32.4%) | ||
| Cerebrovascular disease | 120(9.3%) | 77(8.8%) | 43(10.4%) | ||
| Coronary heart disease | 120(9.3%) | 75(8.5%) | 45(10.9%) | ||
| Lipid metabolism abnormal | 248(19.2%) | 168(19.1%) | 80(19.3%) | ||
| Others | 52(4.0%) | 29(3.3%) | 23(5.6%) | ||
| Diabetic complications, n (%) | 6.842 | 0.446 | |||
| None | 420(34.6%) | 294(35.5%) | 126(32.7%) | ||
| Diabetic foot | 35(2.9%) | 22(2.7%) | 13(3.4%) | ||
| Nephropathy | 104(8.6%) | 68(8.2%) | 36(9.4%) | ||
| Peripheral vascular disease | 134(11.0%) | 97(11.7%) | 37(9.6%) | ||
| Neuropathy | 307(25.3%) | 211(25.5%) | 96(24.9%) | ||
| Retinopathy | 191 (15.7%) | 124(15.0%) | 67(17.4%) | ||
| Others | 23(1.9%) | 13(1.6%) | 10(2.6%) | ||
| Treatment regimen, n (%) | 29.994 | <0.001 | |||
| OAD only | 449(51.5%) | 330(54.5%) | 119(44.7%) | ||
| Insulin (OR GLP-1) | 151(17.3%) | 95(15.7%) | 56(21.1%) | ||
| OAD + insulin (OR GLP-1) | 249(28.6%) | 177(29.2%) | 72(27.4%) | ||
| Not on medication treatment | 20(2.3%) | 4(0.7%) | 16(6.0%) | ||
| Not available | 3(0.3) | 0(0.0%) | 3(1.1%) | ||
Abbreviations: OAD, oral anti-diabetic drug; GLP-1, glucagon like peptide 1.
The Glycemic Control Status of Participants During the COVID-19 Pandemic. (n = 872)
| Variable | All Patients (n= 872) | Self-Management Compliance | |||
|---|---|---|---|---|---|
| Good (n=606) | Poor(n=266) | ||||
| HbA1c, %, median (IQR) | 7.5(6.7–9.2) | 7.4(6.5–8.7) | 8.1(7.2–10.4) | 17.015 | <0.001 |
| <7.0%, n (%) | 162(18.6%) | 137(22.6%) | 25(9.4%) | ||
| 7.0–8.0%, n (%) | 127(14.6%) | 93(15.3%) | 34(12.8%) | ||
| >8.0%, n (%) | 180(20.6%) | 117(19.3%) | 63(23.7%) | ||
| Not Available, n (%) | 403(46.2%) | 259(42.7%) | 144(54.1%) | ||
| FPG, mmol/L, median (IQR) | 7.3(6.4–8.8) | 7.1(6.3–8.2) | 8.4(7.0–10.4) | 23.293 | <0.001 |
| < 6.1 mmol/L, n (%) | 138(15.0%) | 113(18.6%) | 25(9.4%) | ||
| 6.1–7.0 mmol/L, n (%) | 187(21.4%) | 154(25.4%) | 33(12.4%) | ||
| > 7.0 mmol/L, n (%) | 416(47.7%) | 276(45.5%) | 140(52.6%) | ||
| Not Available, n (%) | 131(15.0%) | 63 (10.4%) | 68(25.6%) | ||
| PPG, mmol/L, median (IQR) | 10.7(9.0–13.2) | 10.3(8.9–12.5) | 12.0(9.5–15.5) | 19.869 | <0.001 |
| <8.0 mmol/L, n (%) | 55(6.3%) | 39(6.4%) | 16(6.0%) | ||
| 8.0–10.0 mmol/L, n (%) | 174(20.0%) | 150(24.8%) | 24(9.0%) | ||
| >10.0 mmol/L, n (%) | 318(36.5%) | 216(35.6%) | 102(38.3%) | ||
| Not available, n (%) | 325(37.3%) | 201(33.2%) | 124(46.6%) | ||
| Hypoglycemia(<3.9mmol/L), n (%) | 104(11.9%) | 80(13.3%) | 24(9.0%) | 3.073 | 0.08 |
| Blood pressure | 22.494 | <0.001 | |||
| Good(<140/90mmHg) | 518(59.4%) | 391(64.5%) | 127(47.7%) | ||
| Uncontrolled(≥140/90mmHg) | 204(23.4%) | 128(21.1%) | 76(28.6%) | ||
| Not available | 150(17.2%) | 87(14.4%) | 63(23.7%) | ||
Notes: For glucose monitoring, approximately 85.0% (n=741), 62.7% (n=547), and 53.8% (n=469) of the patients had FPG, PPG, and HbA1c records, respectively.
Abbreviations: FPG, fasting blood glucose; PPG, postprandial plasma glucose.
Impact of Covid-19 Pandemic on Diabetic Self-Management (n=872)
| Variable | All Patients (n=872) | Self-Management Compliance | |||
|---|---|---|---|---|---|
| Good (n=606) | Poor (n=266) | ||||
| Exercise (days/week), mean (SD) | 3.4(2.5) | 4.0(2.3) | 2.1(2.3) | <0.001 | |
| Medication compliance(days/week), mean (SD) | 6.3(1.7) | 6.6(1.2) | 5.8(2.2) | <0.001 | |
| Blood glucose testing (days/week), mean (SD) | 2.3(1.9) | 2.5(1.9) | 1.8(1.8) | <0.001 | |
| Complications monitoring (days/week), mean (SD) | 1.6(2.2) | 1.7(2.3) | 1.2(2.0) | <0.001 | |
| The final mean of diabetes self-management, mean (SD) | 3.4(1.3) | 3.7(1.2) | 2.7(1.3) | <0.001 | |
| Reduce the number of visits to hospitals, n (%) | 629(72.1%) | 455(73.4%) | 184(69.2%) | 1.668 | 0.196 |
| Online consultation, n (%) | 399(45.8%) | 272(44.9%) | 127(47.7%) | 0.609 | 0.435 |
| Offline consultation, n (%) | 608(69.7%) | 448(73.9%) | 160(60.2%) | 16.622 | <0.001 |
| Diabetes-related stress, n (%) | 391(44.8%) | 289(47.7%) | 102(38.3%) | 6.525 | 0.011 |
| Degree of diabetes-related stress(n=286), mean (SD) | 5.3(2.8) | 5.1(2.8) | 6.0(2.8) | ||
| Treatment way, n (%) | 25.197 | <0.001 | |||
| Community hospital | 465(36.2%) | 337(36.2%) | 128(3639%) | ||
| Comprehensive hospital | 699(54.5%) | 506(54.4%) | 193(54.7%) | ||
| Buy medicine online | 17(1.3%) | 11(1.2%) | 6(1.7%) | ||
| Internet clinic | 26(2.0%) | 24(2.6%) | 2(0.6%) | ||
| Mobile phone application | 12(0.9%) | 9(1.0%) | 3(0.8%) | ||
| Others | 64(5.0%) | 43(4.6%) | 21(5.9%) | ||
Abbreviation: SD, Standard Deviation.
Comparison of Self-Management Data Among Different Variables
| Variable | Self-Management Status | |
|---|---|---|
| Mean (SD) | ||
| Age (year) | 0.008 | |
| ≤60 | 3.5(1.3) | |
| >60 | 3.3(1.3) | |
| BMI (kg/m^2) | 0.497 | |
| Underweight (≤18.4) | 3.4(1.8) | |
| Normal BMI (18.5–23.9) | 3.4(1.3) | |
| Overweight (24.0–27.9) | 3.5(1.3) | |
| Obese (≥28) | 3.3(1.4) | |
| Sex | 0.102 | |
| Female | 3.3(1.3) | |
| Male | 3.4(1.3) | |
| Education | <0.001 | |
| Primary school and below | 2.9(1.4) | |
| Junior high | 3.5(1.3) | |
| Senior high | 3.5(1.2) | |
| Bachelor and above | 3.8(1.2) | |
| Living status | 0.049 | |
| Live with family | 3.4(1.3) | |
| Live lonely | 3.1(2.0) | |
| Orders (nursing home, etc.) | 4.1(1.9) | |
| Diabetes duration (year) | 0.070 | |
| <5 | 3.4(1.2) | |
| 5–10 | 3.3(1.4) | |
| 11–15 | 3.3(1.3) | |
| 16–20 | 3.8(1.5) | |
| >20 | 3.3(1.4) | |
| Received diabetes education | <0.001 | |
| Yes | 3.6(1.3) | |
| No | 3.0(1.4) | |
| Self-assessment of diabetes self-management | <0.001 | |
| Good | 3.7(1.2) | |
| Poor | 2.7(1.3) | |
| Complication | 0.115 | |
| Absent | 3.4(1.4) | |
| Present | 3.3(1.2) | |
| Comorbidities | 0.014 | |
| Absent | 3.5(1.4) | |
| Present | 3.3(1.2) | |
| Online consultation | 0.012 | |
| Yes | 3.5(1.4) | |
| No | 3.3(1.2) | |
| HbA1c, % | <0.001 | |
| <7.0% | 3.6(1.2) | |
| 7.0–8.0% | 3.5(1.4) | |
| >8.0% | 3.0(1.1) | |
Note: Nonparametric Test and One-way ANOVA were used.